MyopiaNCT07653074
Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among Youth
An observational study of Myopia and Quality of Life, run by Region Örebro County at 1 site in Sweden.
Trial summary
Society has become increasingly digital, and many everyday services have been replaced by digital self-service solutions. This puts greater demands on our vision and our ability to interpret what we see. At the same time, the number of children with nearsightedness (myopia) has increased rapidly. Read more about this study
- Who is it for?
- Ages Up to 17 yearsHealthy volunteers can take part
- Conditions the study is for
- Myopia, Quality of Life
- What is being tested?
- ophthalmological examination
- How many people
- 300 participants
- Where
- 1 siteSweden
- Study dates
- 27 Oct 2024to 30 May 2029
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 17 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: The study group will be selected from randomised preschools, and schools in Örebro and surrounding areas and we aim to collect a cohort as equal as possible compared to health children in general. Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population.
Who may be able to join
- Healthy children
Who cannot join
- Children with ophthalmological diagnosis followed frequently by the ophthalmological clinic
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Sweden1 site, 1 recruiting
- Recruiting
Örebro university hospital
Örebro
Alexandra Wrede, M.D., +358400791907, alexandra.wrede@regionorebrolan.se
About this study
Society has become increasingly digital, and many everyday services have been replaced by digital self-service solutions. This puts greater demands on our vision and our ability to interpret what we see. At the same time, the number of children with nearsightedness (myopia) has increased rapidly. In some parts of Asia, as many as 60-70% of students in seventh grade are nearsighted, and a similar trend may develop in Europe.
Nearsightedness is becoming a growing challenge in pediatric eye care. High myopia can lead to complications that require early detection and prevention. There are now several ways to slow down its progression, such as special contact lenses, glasses, and eye drops. However, the scientific evidence for these treatments varies, and there are currently no national or Nordic guidelines on how to use them. In addition, myopia may have a major impact on children's quality of life.
Read more
Currently, there is no validated Swedish questionnaire that measures vision related quality of life across all age groups in children and adolescents. To address this, researchers in the United States developed the Pediatric Eye Questionnaire (PedEyeQ) in 2019. It is already available in English and Spanish and takes into account both the child's and the parent's perspectives on vision and daily life.
The aim of this study is to translate, culturally adapt and test the PedEyeQ in Swedish children and adolescents, and to investigate how common refractive errors, especially nearsightedness - are today compared to 20-30 years ago.
The study will include 300 healthy children and adolescents aged 0-17 years, divided into three age groups: 0-4 years, 5-11 years, and 12-17 years. Participants will be recruited through child health centers, preschools, and schools in the Örebro region.
All participants will visit the eye clinic for a detailed eye examination, including:
- Testing distance and near visual acuity
- Measuring eye refraction (with and without eye drops that temporarily relax the eye's focusing muscles)
- Imaging the retina using Optical Coherence Tomography (OCT)
- Measuring eye length and corneal shape
- Checking eye pressure and contrast sensitivity
Children and parents will also answer questions about how the child's vision affects everyday life and wellbeing. For the youngest children (0-4 years), only parents will answer the questions.
The PedEyeQ will be translated into Swedish following the International Society for Pharmacoeconomics and Outcome Research (ISPOR) guidelines to make sure it is culturally relevant and easy to understand. The Swedish version will then be tested to ensure it is accurate and reliable.
All information collected in the study will be stored securely and anonymously. The results will also be compared with data from a similar cohort conducted in the 1990s to see if vision problems have become more common over time.
This project will provide new knowledge about children's vision and quality of life in Sweden. A validated Swedish version of the PedEyeQ can be used both in healthcare and research to better understand how vision affects children's daily lives. The study will also offer updated information on the frequency of refractive errors among Swedish children and adolescents - knowledge that is essential for developing preventive strategies and improving eye care for the future.
Read the detailed description
Society has undergone extensive digitalization, in which many service functions have been replaced by digital self-service solutions. This development requires a good visual function and on the ability to interpret visual information. Concurrently, there has been a marked increase in nearsightedness (myopia) among children. In parts of Asia, 60-70% of students in seventh grade are myopic, and a similar trend may emerge in Europe.
The increase of myopia might become major challenge within pediatric ophthalmology. High myopia can lead to vision-related complications that require early diagnosis and preventive measures. Preventive interventions-such as specialized contact lenses, spectacle designs, and pharmacological treatments as for example low-dose atropine, are now available on the market. However, the scientific evidence supporting these methods varies, and there is currently no national or Nordic consensus regarding their implementation. Furthermore the condition may have substantial implications for affected children's quality of life.
At present, there is no validated Swedish-language instrument for assessing vision-related quality of life in children and adolescents that encompasses all age groups, despite the widely recognized importance of such measures from both a Patient-Reported Outcome Measure (PROM) and Patient-Reported Experience Measure (PREM) perspective. A new questionnaire, the Paediatric Eye Questionnaire (PedEyeQ) was developed in the United States in 2019 for children and adolescents aged 0-17 years. Since its introduction, it has been used in English and subsequently translated into Spanish. The questionnaire comprises four domains measuring different aspects of vision-related quality of life, with each domain consisting of ten questions. To achieve a comprehensive understanding, the questionnaire incorporates both the child's and the parent's perspectives, and it includes separate age-appropriate versions for different developmental stages.
The aim of this study is to validate the PedEyeQ on a healthy Swedish cohort and to study the prevalence and changes in the amount of refractive errors in the same cohort and compare them to another healthy cohort investigated two decades ago.
Validation of PedEyeQ: We intend to translate the PedEyeQ into Swedish and validate the instrument in a cohort of healthy children and adolescents born in Sweden. The study group will consist of 300 participants aged 0-17 years, divided into the following age-based subgroups corresponding to the PedEyeQ versions: 0-4 years, 5-11 years, and 12-17 years, with 100 participants in each group. Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population. Recruitment will primarily take place through child healthcare centers, preschools, and schools in Örebro and surrounding areas.
Participants will be invited to the ophthalmology clinic for a comprehensive examination, including: assessment of distance and near visual acuity, optical coherence tomography (OCT) to document retinal structure, PedEyeQ for assessment of vision-related quality of life, and the Pediatric Quality of Life Inventory (PedsQL) for assessment of general quality of life.
For children aged 0-4 years, only parents will complete the quality-of-life assessment. In the older groups, both the child and the parents will complete the questionnaires independently, allowing for comparison between the two perspectives.
The validation process will follow the International Society for Pharmacoeconomics and Outcome Research (ISPOR) recommendations for the translation and cultural adaptation of questionnaires. The original American PedEyeQ will be translated using a forward-backward translation procedure. The forward translation from English to Swedish will be carried out by a physician with strong subject knowledge and proficiency in both languages. The translation will be reviewed and proofread by an expert panel consisting of the principal supervisor and co-supervisors. The finalized Swedish version will then be back-translated into English. Emphasis during translation will be placed on conceptual and cultural equivalence, rather than literal translation. The research team will discuss any discrepancies between the original and back-translated versions to establish a final Swedish version of the instrument.
The Swedish questionnaire will then be tested in the described healthy study population. To ensure that participants can understand and adequately respond to the items, all participants will take part in a cognitive interview regarding the questionnaire. Following data collection, psychometric analyses will be conducted to evaluate validity, reliability, reproducibility, responsiveness, and factor structure.
Prevalence of refractive errors - The cohort described above will be recruited as previously outlined. In addition to completing the questionnaires, all participating children will undergo a comprehensive ophthalmological examination according to a standardized protocol, which includes measurements of several factors influencing ocular refraction.
The examination will include: Assessment of distance and near visual acuity, autorefractor measurements both with and without cycloplegia (meaning after administration of dilating eye drops to temporarily suspend accommodation and obtain accurate refraction values), Optical Coherence Tomography (OCT) to measure retinal thickness and to detect potential pathology such as edema, deposits, or thinning, Axial length measurement, non-invasive corneal mapping of corneal thickness, curvature, and refractive power using Pentacam, measurement of intraocular pressure using a non-contact, non-anesthetic method, and assessment of contrast sensitivity.
All collected data will be stored in a dedicated, pseudonymized research database (FoU database). Descriptive analyses will be performed to determine the prevalence of refractive errors within the study population. The cohort will also be compared to a corresponding reference group examined during the 1990s, in order to assess potential temporal changes in the prevalence of refractive errors among children and adolescents.
For statistical analysis, the Mann-Whitney U test will be used to compare continuous variables, while Fisher's exact test and the Chi-square test will be applied for comparisons of dichotomous variables. Regression analyses will be conducted to explore associations between risk factors and myopia, as well as relationships between myopia and quality of life.
Furthermore, the described cohort will serve as a reference population, allowing for the extraction of age- and sex-matched control groups for future pediatric ophthalmological studies.
- Conditions
- Myopia, Quality of Life
- Being tested
- ophthalmological examination
- Keywords
- Quality of life, myopia, Sweden
- Medical subject headings
- Myopia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ophthalmological examinationDiagnostic test
The examination will include: Assessment of distance and near visual acuity, Autorefraction measurements both with and without cycloplegia (i.e., after administration of dilating eye drops to temporarily suspend accommodation and obtain accurate refraction values), Optical Coherence Tomography (OCT) to measure retinal thickness and to detect potential pathology such as edema, deposits, or thinning, Axial length measurement, Non-invasive corneal mapping of corneal thickness, curvature, and refractive power using Pentacam,Measurement of intraocular pressure using a non-contact, non-anesthetic method, and Assessment of contrast sensitivity.
It will also include questionnaires as the PedEyeQ described earlier, the PedQoL.
| Study group | Role | What they receive |
|---|---|---|
| Healthy children 0-17 years | The study group will consist of 300 participants aged 0-17 years, divided into the following age-based subgroups corresponding to the PedEyeQ versions: 0-4 years, 5-11 years, and 12-17 years, with 100 participants in each group. Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population. Recruitment will primarily take place through child health centers, preschools, and schools in Örebro and surrounding areas. Receives: Diagnostic Test: ophthalmological examination |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of refractive errors
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jun 2026
- Study start27 Oct 2024
- Primary completion30 May 2027 (estimated)
- Study completion30 May 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for MyopiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 300 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Region Örebro County
- Sponsor type
- University, hospital or other
- Collaborators
- Sahlgrenska University Hospital, Göteborg University
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07653074
- Sponsor's protocol ID
- Region Örebro County
- Status last verified
- Oct 2025
- First submitted
- 11 Jun 2026
- Last updated
- 1 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Gronlund MA, Andersson S, Aring E, Hard AL, Hellstrom A. Ophthalmological findings in a sample of Swedish children aged 4-15 years. Acta Ophthalmol Scand. 2006 Apr;84(2):169-76. doi: 10.1111/j.1600-0420.2005.00615.x.
PubMed 16637831Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P; ISPOR Task Force for Translation and Cultural Adaptation. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005 Mar-Apr;8(2):94-104. doi: 10.1111/j.1524-4733.2005.04054.x.
PubMed 15804318Hatt SR, Leske DA, Castaneda YS, Wernimont SM, Liebermann L, Cheng-Patel CS, Birch EE, Holmes JM. Development of Pediatric Eye Questionnaires for Children With Eye Conditions. Am J Ophthalmol. 2019 Apr;200:201-217. doi: 10.1016/j.ajo.2019.01.001. Epub 2019 Jan 14.
PubMed 30653960Cooper J, Tkatchenko AV. A Review of Current Concepts of the Etiology and Treatment of Myopia. Eye Contact Lens. 2018 Jul;44(4):231-247. doi: 10.1097/ICL.0000000000000499.
PubMed 29901472Li SM, Wei S, Atchison DA, Kang MT, Liu L, Li H, Li S, Yang Z, Wang Y, Zhang F, Wang N. Annual Incidences and Progressions of Myopia and High Myopia in Chinese Schoolchildren Based on a 5-Year Cohort Study. Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):8. doi: 10.1167/iovs.63.1.8.
PubMed 34989760
Study at a glance
From the registry record, last updated by the sponsor on 1 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among Youth
- ClinicalTrials.gov ID
- NCT07653074
- Acronym / sponsor ID
- Region Örebro County
- Conditions
- Myopia, Quality of Life
- Keywords
- Quality of life, myopia, Sweden
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Region Örebro CountyUniversity, hospital or other
- Collaborators
- Sahlgrenska University Hospital, Göteborg University
- Study start
- 27 Oct 2024 (actual)
- Primary completion
- 30 May 2027 (estimated)
- Study completion
- 30 May 2029 (estimated)
- First posted
- 17 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Society has become increasingly digital, and many everyday services have been replaced by digital self-service solutions. This puts greater demands on our vision and our ability to interpret what we see. At the same time, the number of children with nearsightedness (myopia) has increased rapidly. In some parts of Asia, as many as 60-70% of students in seventh grade are nearsighted, and a similar trend may develop in Europe.
Nearsightedness is becoming a growing challenge in pediatric eye care. High myopia can lead to complications that require early detection and prevention. There are now several ways to slow down its progression, such as special contact lenses, glasses, and eye drops. However, the scientific evidence for these treatments varies, and there are currently no national or Nordic guidelines on how to use them. In addition, myopia may have a major impact on children's quality of life.
Currently, there is no validated Swedish questionnaire that measures vision related quality of life across all age groups in children and adolescents. To address this, researchers in the United States developed the Pediatric Eye Questionnaire (PedEyeQ) in 2019. It is already available in English and Spanish and takes into account both the child's and the parent's perspectives on vision and daily life.
The aim of this study is to translate, culturally adapt and test the PedEyeQ in Swedish children and adolescents, and to investigate how common refractive errors, especially nearsightedness - are today compared to 20-30 years ago.
The study will include 300 healthy children and adolescents aged 0-17 years, divided into three age groups: 0-4 years, 5-11 years, and 12-17 years. Participants will be recruited through child health centers, preschools, and schools in the Örebro region.
All participants will visit the eye clinic for a detailed eye examination, including:
- Testing distance and near visual acuity
- Measuring eye refraction (with and without eye drops that temporarily relax the eye's focusing muscles)
- Imaging the retina using Optical Coherence Tomography (OCT)
- Measuring eye length and corneal shape
- Checking eye pressure and contrast sensitivity
Children and parents will also answer questions about how the child's vision affects everyday life and wellbeing. For the youngest children (0-4 years), only parents will answer the questions.
The PedEyeQ will be translated into Swedish following the International Society for Pharmacoeconomics and Outcome Research (ISPOR) guidelines to make sure it is culturally relevant and easy to understand. The Swedish version will then be tested to ensure it is accurate and reliable.
All information collected in the study will be stored securely and anonymously. The results will also be compared with data from a similar cohort conducted in the 1990s to see if vision problems have become more common over time.
This project will provide new knowledge about children's vision and quality of life in Sweden. A validated Swedish version of the PedEyeQ can be used both in healthcare and research to better understand how vision affects children's daily lives. The study will also offer updated information on the frequency of refractive errors among Swedish children and adolescents - knowledge that is essential for developing preventive strategies and improving eye care for the future.
Detailed description
Society has undergone extensive digitalization, in which many service functions have been replaced by digital self-service solutions. This development requires a good visual function and on the ability to interpret visual information. Concurrently, there has been a marked increase in nearsightedness (myopia) among children. In parts of Asia, 60-70% of students in seventh grade are myopic, and a similar trend may emerge in Europe.
The increase of myopia might become major challenge within pediatric ophthalmology. High myopia can lead to vision-related complications that require early diagnosis and preventive measures. Preventive interventions-such as specialized contact lenses, spectacle designs, and pharmacological treatments as for example low-dose atropine, are now available on the market. However, the scientific evidence supporting these methods varies, and there is currently no national or Nordic consensus regarding their implementation. Furthermore the condition may have substantial implications for affected children's quality of life.
At present, there is no validated Swedish-language instrument for assessing vision-related quality of life in children and adolescents that encompasses all age groups, despite the widely recognized importance of such measures from both a Patient-Reported Outcome Measure (PROM) and Patient-Reported Experience Measure (PREM) perspective. A new questionnaire, the Paediatric Eye Questionnaire (PedEyeQ) was developed in the United States in 2019 for children and adolescents aged 0-17 years. Since its introduction, it has been used in English and subsequently translated into Spanish. The questionnaire comprises four domains measuring different aspects of vision-related quality of life, with each domain consisting of ten questions. To achieve a comprehensive understanding, the questionnaire incorporates both the child's and the parent's perspectives, and it includes separate age-appropriate versions for different developmental stages.
The aim of this study is to validate the PedEyeQ on a healthy Swedish cohort and to study the prevalence and changes in the amount of refractive errors in the same cohort and compare them to another healthy cohort investigated two decades ago.
Validation of PedEyeQ: We intend to translate the PedEyeQ into Swedish and validate the instrument in a cohort of healthy children and adolescents born in Sweden. The study group will consist of 300 participants aged 0-17 years, divided into the following age-based subgroups corresponding to the PedEyeQ versions: 0-4 years, 5-11 years, and 12-17 years, with 100 participants in each group. Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population. Recruitment will primarily take place through child healthcare centers, preschools, and schools in Örebro and surrounding areas.
Participants will be invited to the ophthalmology clinic for a comprehensive examination, including: assessment of distance and near visual acuity, optical coherence tomography (OCT) to document retinal structure, PedEyeQ for assessment of vision-related quality of life, and the Pediatric Quality of Life Inventory (PedsQL) for assessment of general quality of life.
For children aged 0-4 years, only parents will complete the quality-of-life assessment. In the older groups, both the child and the parents will complete the questionnaires independently, allowing for comparison between the two perspectives.
The validation process will follow the International Society for Pharmacoeconomics and Outcome Research (ISPOR) recommendations for the translation and cultural adaptation of questionnaires. The original American PedEyeQ will be translated using a forward-backward translation procedure. The forward translation from English to Swedish will be carried out by a physician with strong subject knowledge and proficiency in both languages. The translation will be reviewed and proofread by an expert panel consisting of the principal supervisor and co-supervisors. The finalized Swedish version will then be back-translated into English. Emphasis during translation will be placed on conceptual and cultural equivalence, rather than literal translation. The research team will discuss any discrepancies between the original and back-translated versions to establish a final Swedish version of the instrument.
The Swedish questionnaire will then be tested in the described healthy study population. To ensure that participants can understand and adequately respond to the items, all participants will take part in a cognitive interview regarding the questionnaire. Following data collection, psychometric analyses will be conducted to evaluate validity, reliability, reproducibility, responsiveness, and factor structure.
Prevalence of refractive errors - The cohort described above will be recruited as previously outlined. In addition to completing the questionnaires, all participating children will undergo a comprehensive ophthalmological examination according to a standardized protocol, which includes measurements of several factors influencing ocular refraction.
The examination will include: Assessment of distance and near visual acuity, autorefractor measurements both with and without cycloplegia (meaning after administration of dilating eye drops to temporarily suspend accommodation and obtain accurate refraction values), Optical Coherence Tomography (OCT) to measure retinal thickness and to detect potential pathology such as edema, deposits, or thinning, Axial length measurement, non-invasive corneal mapping of corneal thickness, curvature, and refractive power using Pentacam, measurement of intraocular pressure using a non-contact, non-anesthetic method, and assessment of contrast sensitivity.
All collected data will be stored in a dedicated, pseudonymized research database (FoU database). Descriptive analyses will be performed to determine the prevalence of refractive errors within the study population. The cohort will also be compared to a corresponding reference group examined during the 1990s, in order to assess potential temporal changes in the prevalence of refractive errors among children and adolescents.
For statistical analysis, the Mann-Whitney U test will be used to compare continuous variables, while Fisher's exact test and the Chi-square test will be applied for comparisons of dichotomous variables. Regression analyses will be conducted to explore associations between risk factors and myopia, as well as relationships between myopia and quality of life.
Furthermore, the described cohort will serve as a reference population, allowing for the extraction of age- and sex-matched control groups for future pediatric ophthalmological studies.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Day
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Healthy children 0-17 years | – | Diagnostic Test: ophthalmological examinationThe study group will consist of 300 participants aged 0-17 years, divided into the following age-based subgroups corresponding to the PedEyeQ versions: 0-4 years, 5-11 years, and 12-17 years, with 100 participants in each group. Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population. Recruitment will primarily take place through child health centers, preschools, and schools in Örebro and surrounding areas. |
Who may qualify
- Ages
- Up to 17 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- The study group will be selected from randomised preschools, and schools in Örebro and surrounding areas and we aim to collect a cohort as equal as possible compared to health children in general. Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population.
Key inclusion criteria (1 listed)
- Healthy children
Key exclusion criteria (1 listed)
- Children with ophthalmological diagnosis followed frequently by the ophthalmological clinic
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ophthalmological examinationThe examination will include: Assessment of distance and near visual acuity, Autorefraction measurements both with and without cycloplegia (i.e., after administration of dilating eye drops to temporarily suspend accommodation and obtain accurate refraction values), Optical Coherence Tomography (OCT) to measure retinal thickness and to detect potential pathology such as edema, deposits, or thinning, Axial length measurement, Non-invasive corneal mapping of corneal thickness, curvature, and refractive power using Pentacam,Measurement of intraocular pressure using a non-contact, non-anesthetic method, and Assessment of contrast sensitivity. It will also include questionnaires as the PedEyeQ described earlier, the PedQoL. | Diagnostic test | Healthy children 0-17 years |
Primary outcome
Prevalence of refractive errors
Time frame: 1 day
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Sep 2026.
- Background: PubMed 16637831Gronlund MA, Andersson S, Aring E, Hard AL, Hellstrom A. Ophthalmological findings in a sample of Swedish children aged 4-15 years. Acta Ophthalmol Scand. 2006 Apr;84(2):169-76. doi: 10.1111/j.1600-0420.2005.00615.x.
- Background: PubMed 15804318Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P; ISPOR Task Force for Translation and Cultural Adaptation. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005 Mar-Apr;8(2):94-104. doi: 10.1111/j.1524-4733.2005.04054.x.
- Background: PubMed 30653960Hatt SR, Leske DA, Castaneda YS, Wernimont SM, Liebermann L, Cheng-Patel CS, Birch EE, Holmes JM. Development of Pediatric Eye Questionnaires for Children With Eye Conditions. Am J Ophthalmol. 2019 Apr;200:201-217. doi: 10.1016/j.ajo.2019.01.001. Epub 2019 Jan 14.
- Background: PubMed 29901472Cooper J, Tkatchenko AV. A Review of Current Concepts of the Etiology and Treatment of Myopia. Eye Contact Lens. 2018 Jul;44(4):231-247. doi: 10.1097/ICL.0000000000000499.
- Background: PubMed 34989760Li SM, Wei S, Atchison DA, Kang MT, Liu L, Li H, Li S, Yang Z, Wang Y, Zhang F, Wang N. Annual Incidences and Progressions of Myopia and High Myopia in Chinese Schoolchildren Based on a 5-Year Cohort Study. Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):8. doi: 10.1167/iovs.63.1.8.
Related trials for Myopia
Recruiting
Managing Premyopia in Chinese Children Using Artificial Intelligence Assisted Defocus Incorporated Multiple Segments Based Spectacle Lens: a Randomized Controlled Clinical Trial
Pre-myopia, Myopia
Not yet recruiting
BRIGHT-LIGHT: Studying Red Light Therapy for Severe Short-Sightedness or Short-Sightedness That Worsens Despite Standard Treatment
Myopia, Myopia Progressing
Not yet recruiting
Clinical Performance and Outcomes After Toric Lens Transition
Astigmatism
Active, not recruiting
Effect of IOP Lowering on Progressive HM
High Myopia, Intraocular Pressure
Recruiting
Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2
Hyperopia and Myopia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Myopia and Quality of Life, run by Region Örebro County at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 1 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Alexandra UC Wrede, MD (+358400791907, alexandra.wrede@regionorebrolan.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of refractive errors (time frame: 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07653074, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2026.